TP53 and non-small cell lung carcinoma: Despite the establishment of an oncogene-centric molecular classification paradigm for this lung cancer [6], the precise role of p53 in NSCLC remains unclear, particularly in two of its primary subtypes with distinct cellular origins, namely, lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC).